Current tendencies in treatment of congenital hypogonadotropic hypogonadism in boys: clinical cases’ analysis
AbstractThis article includes analysis of clinical cases of isolated congenital hypogonadotropic hypogonadism and hypogonadism due to hypopituitarism in boys. We evaluated the timeliness of diagnosis and therapy onset and effectiveness of combination therapy with recombinant follicle stimulating hormone and human chorionic gonadotropin using.
Keywords:congenital hypogonadotropic hypogonadism, hypopituitarism, puberty delay, recombinant follicle stimulating hormone, human chorionic gonadotropin
Funding. The study had no sponsor support.
Conflict of interests. The authors declare no conflict of interests.
For citation: Latyshev O.Yj., Kiseleva E.V., Okminyan G.F., Kokoreva K.D., Kasatkina E.P., Samsonova L.N. Current tendencies in treatment of congenital hypogonadotropic hypogonadism in boys: clinical cases' analysis. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2020; 9 (2): 80-5. DOI: 10.33029/2304-9529-2020-9-2-80-85 (in Russian)
References
1. Boehm U., et al. European Consensus Statement on congenital hypogonadotropic hypogonadism - pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015; 11: 547-64; published online 21 July 2015.
2. Mody S., Brown M.R., Parks J.S. The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab. 2002; 16 (3): 421-31.
3. Sabanegh E., et al. Testosterone replacement in the infertile man. Transl Androl Urol. 2016; 5 (6): 859-65.
4. Shoskes J.J., Wilson M.K., Spinner M.L. Pharmacology of testosterone replacement therapy preperations. Transl Androl Urol. 2016; 5 (6): 834-43.
5. Latyshev O. Yu., Brzhezinskaya L.B., Okminyan G.F., Kiseleva E.V., Kokoreva K.D., Samsonova L.N., et al. New technologies in the treatment of hypogonadotropic hypogonadism in pediatric practice. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2019; 8 (4): 67-71. (in Russian)
6. Dwyer A.A., Tiemensma J., Quinton R., Pitteloud N., Morin D. Adherence to treatment in men with hypogonadotropic hypogonadism. Clin Endocrinol. 2017; 86: 377-83.
7. Varimo T., Hero M., Laitinen E.M., Sintonen H, Ravio T. Health-related quality of life in male patients with congenital hypogonadotropic hypogonadism. Clin Endocrinol. 2015; 83: 141-3.
8. Kelsey T.W., Miles A., Mitchell R.T., Anderson R.A., Wallace W.H. A normative model of serum inhibin B in young males. PLoS One. 2016; 11 (4): e0153843.